オープン アクセスを義務付けられた論文 - Ramy R. Saleh, MD, MSc, FRCPC詳細
一般には非公開: 1 件
Real-world assessment of clinical outcomes in patients with metastatic renal cell carcinoma with or without sarcomatoid features treated with first-line systemic therapies
GBN Sawaya, A Dragomir, LA Wood, C Kollmannsberger, NS Basappa, ...
European Urology Oncology 7 (3), 570-580, 2024
委任: Fonds de recherche du Québec - Santé
一般公開: 5 件
Impact on costs and outcomes of multi-gene panel testing for advanced solid malignancies: a cost-consequence analysis using linked administrative data
A Hernando-Calvo, P Nguyen, PL Bedard, KKW Chan, RR Saleh, ...
EClinicalMedicine 69, 2024
委任: Genome Canada, Ontario Institute for Cancer Research
Utilization trends of novel hormonal agents in metastatic castration-resistant prostate cancer in Quebec
J Hu, AG Aprikian, RR Saleh, A Dragomir
Current Oncology 29 (11), 8626-8637, 2022
委任: Fonds de recherche du Québec - Santé
Pilot study investigating the prognostic significance of thymidine phosphorylase expression in patients with metastatic breast cancer: A single institution retrospective analysis
AL Tedeschi, Z Eslami, E Garoufalis, RR Saleh, A Omeroglu, G Altinel, ...
OncoTargets and therapy, 911-919, 2015
委任: Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé
A phase 2 trial of peri-operative avelumab and chemotherapy for locally advanced gastro-esophageal adenocarcinoma: Association of AGR2/AP-1 complex CD8 T-cells and M2-Tumour …
L Ferri, T Alcindor, J Tankel, P Fiset, S Pal, T Opu, M Strasser, ...
委任: US Department of Defense
Concurrent dose-finding of a novel cancer drug with and without a second agent
NA Wages, RR Saleh, TM Braun
Journal of Clinical and Translational Science 7 (1), e126, 2023
委任: US National Institutes of Health
公開と助成金に関する情報は、コンピュータ プログラムによって自動的に決定されます